Companies and countries must take urgent action to increase access to these life-saving treatments Only 4,800 people with drug-resistant tuberculosis (DR-TB) in 2016 were treated with two newer and much more effective medicines, even though these have now been on the market for up to four years,...
Two years after two new drugs to treat tuberculosis—the first in over 50 years—were conditionally approved for use, only 2% of the 150,000 people who need them have been able to access them, according to Médecins Sans Frontières (MSF). MSF and other treatment providers are showing that stronger TB...
More than two years after drug approved, only 180 people globally have received it. Geneva, 24 February 2016 Médecins Sans Frontières (MSF) today expressed great concern at the high price announced for the new tuberculosis (TB) drug delamanid. Japanese pharmaceutical company Otsuka said that it...
With winter settling in in eastern Ukraine, Médecins Sans Frontières (MSF) is continuing its support to hospitals on both sides of the frontline, and expanding its psychological assistance to help people living in some of the hardest hit areas. Despite the signing of a ceasefire agreement on 5...
Following months of intense conflict, an increasingly alarming humanitarian situation is unfolding in eastern Ukraine, Medecins Sans Frontieres (MSF) said. Hospitals have been shelled, tens of thousands of people are displaced from their homes, and thousands of casualties have been reported. "The...
Drug resistant tuberculosis (DR-TB) is on the rise in Southern Africa, fueled on the one hand by high HIV prevalence, and on the other by its highly contagious nature. The disease reaches deep into rural Zimbabwe where MSF runs a DR-TB project. Steps need to be taken urgently to curb transmission...
Phumeza TISILE, co-author of the DR-TB Manifesto* and XDR-TB survivor, delivers urgent plea to World Health Assembly delegates on behalf of 50,000 supporters worldwide On the eve of the World Health Assembly adopting an ambitious 20-year global plan to address tuberculosis (TB) and drug-resistant...
24th March is the World Tuberculosis (TB) Day. A new briefing paper by Médecins Sans Frontières (MSF) outlines why the alarming spread of deadly strains of drug-resistant tuberculosis (DR-TB) is one of the biggest global health threats we face today. It calls on governments, pharmaceutical...
